On Monday 2 February, we were honoured to represent the ovarian cancer community at a special reception at 10 Downing Street, held ahead of World Cancer Day on Wednesday 4 February.
Our CEO, Catherine Hart, attended the event alongside two of our inspiring campaigners, Reeta and Catherine, helping to ensure that the voices of those affected by ovarian cancer were heard at the heart of government.
I was proud to join our outstanding campaigners, Reeta and Catherine, in representing Target Ovarian Cancer at Downing Street. With World Cancer Day later this week and the National Cancer Plan imminent, it’s vital that ovarian cancer is firmly on the agenda. The voices and experiences of those affected must be at the heart of decisions that shape better outcomes and save lives.
Transforming the future of cancer care requires focus, leadership, and, crucially, listening to those with lived experience – and we’re proud to have been part of that vital conversation.
During the evening, we had the opportunity to connect with representatives from other cancer charities, as well as influential figures from the health sector, including having a conversation with Wes Streeting, Secretary of State for Health and Social Care.
Reeta, from Loughborough, said:
“My initial reaction to being invited to 10 Downing Street was one of genuine delight, coupled with a deep sense of privilege and honour to be standing alongside Target Ovarian Cancer.
As a cancer survivor, and a woman of Asian heritage, this invitation felt especially meaningful. I hope my presence helped underscore the vital importance of bringing patient voices into conversations with key decision-makers and ensuring that people from ethnic minorities play a part in those discussions. It’s through these conversations that we exercise our power to shape policies and drive improvements in cancer outcomes for generations to come.
Catherine, from Harpenden, added:
"I was honoured to attend this World Cancer Day reception, which held significant personal meaning for me as an ovarian cancer survivor. My experience with diagnosis, treatment, and recovery has deepened my respect for the resilience of patients, families, and healthcare professionals.
Early detection is critical, yet most ovarian cancer cases are still identified at advanced stages. It’s essential that we continue to raise awareness of symptoms and ensure that patient perspectives inform decision-making and drive meaningful change.
We now await the publication of the National Cancer Plan and look forward to sharing our thoughts on what it could mean for everyone affected by ovarian cancer.
